LINDSEY LIRA: Open Payments
NPI 1023231099 · EDWARDSBURG, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,194 in 65 payments from 20 companies in 2025. Trend: 2023 $526 · 2024 $1,379 · 2025 $1,194
Food & beverage: $1,194
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $269 |
| Novo Nordisk Inc | 14 | $197 |
| Amgen Inc. | 9 | $138 |
| PFIZER INC. | 4 | $72 |
| ABBVIE INC. | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Exact Sciences Corporation | 4 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
Products named: FARXIGA, Wegovy, AIRSUPRA, EVENITY, OTEZLA, REXULTI, Auvelity, The Cologuard Plus Collection Kit.
Industry payments across MI — which companies pay providers there.
